US Healthcare Stocks Rise Amid Government Shutdown
ByAinvest
Sunday, Oct 5, 2025 9:06 am ET2min read
JNJ--
Pfizer, Novo Nordisk, and Johnson & Johnson were notable healthcare stocks in focus. Pfizer reported strong earnings, driven by its COVID-19 vaccine sales, while Novo Nordisk plans to launch a new obesity pill through telehealth platforms after U.S. approval, potentially by 2026. Johnson & Johnson's stock performance was mixed, reflecting the company's ongoing legal battles and regulatory challenges [2].
In the broader market, lithium Americas jumped more than 32% overnight after the U.S. government confirmed speculation that it would take a 5% equity stake in the company. The deal includes an approximate $2.3 billion federal loan to allow the company to move forward on extracting the silver-white metal used in electric vehicle batteries from its massive mine in northern Nevada [1].
Utility and power generator AES climbed 10% on media reports that the Virginia company was near a deal to be acquired by BlackRock subsidiary Global Infrastructure Partners [1].
Political uncertainty is also looming over Japan's markets, with the ruling Liberal Democratic Party due to choose a new leader and prime minister later this week to replace embattled Prime Minister Shigeru Ishiba. The Bank of Japan reported a slight improvement in business sentiment among major manufacturers, raising the odds that the central bank will increase its key interest rate to counter inflation that has topped its target range of about 2% for some time [1].
In Europe, Germany's DAX gained 0.5%, the CAC 40 in Paris rose 0.4%, and Britain’s FTSE climbed 0.7% at midday. In Asia, Japan's Nikkei 225 index shed 0.9%, while South Korea's Kospi gained 0.9% and Taiwan's Taiex added 0.6% [1].
The broader stock market has been on a nearly relentless run since hitting a low in April on expectations that President Donald Trump’s tariffs won’t derail global trade and that the Federal Reserve will cut interest rates several times to boost the slowing job market. The Fed just delivered its first cut of the year, and officials have penciled in more to give the job market a boost [1].
When Wall Street will get the next data reports on the job market is uncertain, because the shutdown would delay the release of several important reports, including Friday’s September jobs report. The Department of Labor has said that the Bureau of Labor Statistics will completely cease operations if there’s a lapse [1].
NVO--
PFE--
Wall Street's major market averages closed mixed on Friday due to the US government shutdown, which entered its third day. Despite this, the Dow, S&P 500, and Nasdaq Composite advanced by 1.1%, 1.08%, and 1.32% respectively for the week. Pfizer, Novo Nordisk, and Johnson & Johnson were notable healthcare stocks in focus.
Wall Street's major market averages closed mixed on Friday, September 12, 2025, amidst the ongoing U.S. government shutdown. Despite the uncertainty, the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite advanced by 1.1%, 1.08%, and 1.32% respectively for the week. The shutdown, now in its third day, has had a limited impact on the broader stock market, with investors focusing more on corporate earnings and broader economic trends [1].Pfizer, Novo Nordisk, and Johnson & Johnson were notable healthcare stocks in focus. Pfizer reported strong earnings, driven by its COVID-19 vaccine sales, while Novo Nordisk plans to launch a new obesity pill through telehealth platforms after U.S. approval, potentially by 2026. Johnson & Johnson's stock performance was mixed, reflecting the company's ongoing legal battles and regulatory challenges [2].
In the broader market, lithium Americas jumped more than 32% overnight after the U.S. government confirmed speculation that it would take a 5% equity stake in the company. The deal includes an approximate $2.3 billion federal loan to allow the company to move forward on extracting the silver-white metal used in electric vehicle batteries from its massive mine in northern Nevada [1].
Utility and power generator AES climbed 10% on media reports that the Virginia company was near a deal to be acquired by BlackRock subsidiary Global Infrastructure Partners [1].
Political uncertainty is also looming over Japan's markets, with the ruling Liberal Democratic Party due to choose a new leader and prime minister later this week to replace embattled Prime Minister Shigeru Ishiba. The Bank of Japan reported a slight improvement in business sentiment among major manufacturers, raising the odds that the central bank will increase its key interest rate to counter inflation that has topped its target range of about 2% for some time [1].
In Europe, Germany's DAX gained 0.5%, the CAC 40 in Paris rose 0.4%, and Britain’s FTSE climbed 0.7% at midday. In Asia, Japan's Nikkei 225 index shed 0.9%, while South Korea's Kospi gained 0.9% and Taiwan's Taiex added 0.6% [1].
The broader stock market has been on a nearly relentless run since hitting a low in April on expectations that President Donald Trump’s tariffs won’t derail global trade and that the Federal Reserve will cut interest rates several times to boost the slowing job market. The Fed just delivered its first cut of the year, and officials have penciled in more to give the job market a boost [1].
When Wall Street will get the next data reports on the job market is uncertain, because the shutdown would delay the release of several important reports, including Friday’s September jobs report. The Department of Labor has said that the Bureau of Labor Statistics will completely cease operations if there’s a lapse [1].

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet